Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 980476831000036118 | bisacodyl 10 mg suppository [1 suppository] (&) bisacodyl 5 mg enteric tablet [3 tablets] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 980476841000036111 | bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has MPUU | bisacodyl 10 mg suppository | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has MPUU | bisacodyl 5 mg enteric tablet | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has MPUU | magnesium carbonate heavy 7.5 g + citric acid 14 g powder for oral liquid, 21.5 g sachet | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has component pack | bisacodyl 10 mg suppository, 1 | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has component pack | bisacodyl 5 mg enteric tablet, 3 | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | has component pack | magnesium carbonate heavy 7.5 g + citric acid 14 g powder for oral liquid, 1 sachet | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | Is a | bisacodyl 5 mg enteric tablet, 3 | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | Is a | magnesium carbonate heavy 7.5 g + citric acid 14 g powder for oral liquid, 1 sachet | false | Inferred relationship | Some | ||
| bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | Is a | bisacodyl 10 mg suppository, 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Go Kit Plus (3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Go Kit sachet, 1 x Bisacodyl (Fresenius Kabi) suppository), 1 pack | Is a | False | bisacodyl 5 mg enteric tablet [3] (&) citric acid 14 g + magnesium carbonate heavy 7.5 g powder for oral liquid [1 x 21.5 g sachet] (&) bisacodyl 10 mg suppository [1], 1 pack | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR